EW Q1 2021 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+7.8% YoY

Gross Profit

$929M76.3% margin

Operating Income

$391M32.1% margin

Net Income

$338M27.8% margin

EPS (Diluted)

$0.54

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$301M

Free Cash Flow

$195M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$2.6B

Stockholders' Equity

$4.7B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+7.8%
Gross Profit	$929M	$858M	+8.3%
Operating Income	$391M	$362M	+8.1%
Net Income	$338M	$311M	+8.9%

Revenue Segments

Transcatheter Heart Valves

$792M65%

Surgical Heart Valve Therapy

$213M18%

Critical Care

$196M16%

Transcatheter Mitral And Tricuspid Therapies

$16M1%

Geographic Segments

UNITED STATES

$675M55%

Europe

$280M23%

JAPAN

$132M11%

Rest of World

$130M11%